Clinical Trials Logo

Uterine Hemorrhage clinical trials

View clinical trials related to Uterine Hemorrhage.

Filter by:

NCT ID: NCT03709849 Not yet recruiting - Clinical trials for Polycystic Ovarian Syndrome

Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility

Start date: February 1, 2019
Phase: Phase 2
Study type: Interventional

This study is to evaluate the effectiveness and safety of Bushen Culuan Decoction in the treatment of anovulatory infertility, including anovulatory abnormal uterine bleeding, polycystic ovarian syndrome, hyperprolactinemia, luteinized unruptured follicle syndrome, corpus luteum insufficiency and ovarian insufficiency, through a randomised, double-blinded, double-dummy, parallel positive controlled, adaptive multicenter clinical trial.

NCT ID: NCT03697733 Completed - Clinical trials for Abnormal Uterine Bleeding

Comparison Efficiency of Oral Etoricoxib Versus Intravenous Fentanyl on Post Operative Pain in Curettage Under TIVA

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

Comparison of the efficiency of oral Etoricoxib versus intravenous Fentanyl on post operative Pain in curettage under TIVA: A randomized controlled trial

NCT ID: NCT03638856 Completed - Infertility, Female Clinical Trials

Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy

Start date: September 30, 2018
Phase: N/A
Study type: Interventional

Research objective To compare effectiveness of oral Misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy Research hypothesis: Null hypothesis Effectiveness of oral misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy is not different from placebo Alternative hypothesis: : Oral Misoprostal for cervical priming in Premenopausal women underwent to diagnostic hysteroscopy is better than placebo

NCT ID: NCT03632824 Completed - Clinical trials for Vaginal Bleeding During Pregnancy

Tranexamic Acid in Pregnancies With Vaginal Bleeding

Start date: February 1, 2016
Phase: N/A
Study type: Interventional

Tranexamic acid has been proposed and used for prevention and management of antepartum and postpartum hemorrhage.

NCT ID: NCT03558321 Completed - Clinical trials for Postmenopausal Bleeding

Relation Between Human Epididymis Protein 4 (HE4) and Endometrial Pathology in Patients With Postmenopausal Bleeding

Start date: June 2014
Phase: N/A
Study type: Interventional

All patients included in the study had single or multiple episodes of postmenopausal bleeding with an endometrial thickness of more than 5mm. full history, general and local examination were done. Transvaginal ultrasound (TVS) was performed .The uterus was scanned in the sagittal plane. The double-layer ET was measured at the widest point between the endometrial-myometrial interfaces.the level of HE4 was measured. All women underwent hystrospopic guided endometrial biopsy. Definitive management was later performed in the form of total abdominal hysterectomy, bilateral salpingo oophrectomy, with or without pelvic lymph nodal dissection and histopathological examination.

NCT ID: NCT03543592 Recruiting - Clinical trials for Postmenopausal Bleeding

Three-dimensional Power Doppler in the Diagnosis of Endometrial Lesions in Patients With Postmenopausal Bleeding

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

100 women suffering post-menopausal bleeding will be included in the study. All the participants will undergo 3D Transvaginal Ultrasound to assess the endometrium and myometrium (for the presence of any focal lesions e.g. polypi) followed by 3D Power Doppler ultrasound assessment of the vascular indices: vascularization index (VI), flow index (FI) and vascularization-flow index (VFI) and endometrial volumes. The results of the ultrasound and Doppler indices will be correlated to the histopathological examination of specimens collected following fractional curettage or hysterectomy.

NCT ID: NCT03441087 Completed - Clinical trials for Abnormal Uterine Bleeding

The Role of TVSG and HS in Determining Endometrial Pathologies

Start date: January 1, 2011
Phase: N/A
Study type: Interventional

Although hysteroscopy (HS) and transvaginal ultrasonography (TVSG) are methods in the diagnosis of AUB, there is some suspicion about their efficacy. The aim of this study was to determine the efficacy and safety of HS and TVSG on diagnosing abnormal uterine bleeding(AUB) .216 women admitted to the investigators clinic (Sisli Ethal Training and Research Hospital, Obstetrics and Gynecology Department Obstetrics Service ) between 21-51 years of age. These patients were divided into two groups; menopause (71women) and pre-menopause (145 women). HS and endometrial sampling were performed both groups after TVSG.The success of these methods was assessed by kappa analysis

NCT ID: NCT03428854 Withdrawn - Adenomyosis Clinical Trials

Adenomyosis: Genomic Mechanisms and Biological Response

Start date: December 1, 2020
Phase:
Study type: Observational

Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.

NCT ID: NCT03404154 Completed - Clinical trials for Postmenopausal Bleeding

Vocal in Assessment of Endometrium in Postmenopause

Start date: January 18, 2018
Phase:
Study type: Observational [Patient Registry]

The unbalanced estrogen with no progesterone will lead to endometrial thickening .This thickening result in endometrial hyperplasia & carcinoma and lead to irregular bleeding

NCT ID: NCT03398811 Completed - Contraception Clinical Trials

Abnormal Uterine Bleeding and Progestin-only Contraceptives

Start date: August 1, 2018
Phase:
Study type: Observational

The use of progestin-only methods of contraception has been increased obviously and progressively over the world in the last few years. Progestin-only contraception is an option for women in whom an estrogen-containing contraceptive is either contraindicated or causes additional health concerns. Progestogen-only pills are contraceptive pills that contain only synthetic progestogens (progestins) and do not contain estrogen . The progestin-only pill is recommended over regular birth control pills for women who are breastfeeding because the mini-pill does not affect milk production. The most common progestin-only method used is the injectable depot medroxy-progesterone acetate which had been approved by Food and Drug Administration since 1992 . depot medroxy-progesterone acetate provides reliable, private, long-acting (three months) and reversible contraception. Users of depot medroxy-progesterone acetate don't need daily taking as well as it doesn't affect the intercourse by any mean. The etonogestrel implant (Implanon) is a single-rod progestin contraceptive method placed subdermally in the inner aspect of upper non dependant arm for three years. Much evidence supports the safety, efficacy, reversibility and acceptability of this contraceptive method. A common reason women choose to discontinue progestin-only contraception is dissatisfaction with its effects on uterine bleeding which occurs in a significant number of users. Information revealed from many clinical trials shows that abnormal uterine bleeding with progestin-only contraception ranging from 10 to 25 % at first year of use.